Maalox Soft Chews
This article was originally published in The Tan Sheet
Executive Summary
Packaging for Novartis Consumer Health's Maalox Soft Chews will include a "Supplement Facts" panel advising consumers to take one chew three times a day as a calcium supplement, as well as "Drug Facts" labeling directing consumption of one to two chews (up to seven per day) for "relief of occasional heartburn," firm says. Reaching food, drug and mass outlets now, Maalox Soft Chews (400 mg calcium carbonate) will come in 30-count bottles in cherry and chocolate flavors. Ads for the product, which will retail for $5.99, will begin in April, Novartis says...
You may also be interested in...
New EU Approvals
The Pink Sheet's list of EU centralized approvals of new active substances has been updated to add two new products, including Ryzneuta, Evive Biotechnology's treatment for chemotherapy-induced neutropenia.
Pair Of Deaths Linked To Recalled Vyaire Medical Respiratory Devices
The US FDA has labelled a recall of more than 6 million Airlife respiratory support devices class I. The recall covers devices manufactured in 2017 or earlier that can fail to provide adequate ventilation.
Over The Counter 2 Apr 2024: Analyzing The Spin-Out Trend In Consumer Health, With HBW’s Malcolm Spicer And Tom Gallen
In this episode, HBW Insight’s Europe and US editors bring their expertise to bear on the current the trend towards standalone OTC companies in global consumer health. We look at four major players: Haleon, which separated from GSK almost two years ago; Kenvue, soon to celebrate its first anniversary as a new company; Sanofi Consumer Healthcare, which is poised to split from its pharma parent; and Bayer, which has decided to buck the trend, holding on to its consumer health division. We discuss some of the advantages of becoming a standalone company, for example in leaning into a wider concept of self-care.